The Impact of Successful Quitting Smoking After Intensive Smoking Cessation Interventions on Morbidity and Mortality Among Smokers With Severe Mental Disorders - A Nationwide Cohort Study From the Danish Smoking Cessation Database
NCT ID: NCT06967636
Last Updated: 2025-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15863 participants
OBSERVATIONAL
2006-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Smoking Cessation Intervention in a Mental Health Day Hospital
NCT05045326
Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics
NCT04796961
Positive Psychology for Smoking Cessation
NCT06632756
Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization
NCT05672914
Enhancing Smoking Cessation in the Homeless Population
NCT01932996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participation in the GSP in Denmark
Exclusion Criteria
* \< 18 years
* No consent to follow-up
* No baseline smoking status
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parker Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sine Holst-Albrechtsen
MD, MSc
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STOPbase
Identifier Type: REGISTRY
Identifier Source: secondary_id
NPR
Identifier Type: REGISTRY
Identifier Source: secondary_id
RCD
Identifier Type: REGISTRY
Identifier Source: secondary_id
2000-54-0013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.